WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has been selected as a full-service preferred provider for translational clinical development services by the Juvenile Diabetes Research Foundation (JDRF) and will share its expertise with academic investigators who are conducting JDRF-funded, early phase clinical trials for type 1 diabetes and its complications.
